PATENT CLAIM ANALYSIS

Application Number: 16028704
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["435", "007230"]

Abstract:
The invention generally relates to diagnostic, prognostic, and monitoring methods and assays for breast cancer and kits that may be used in such methods. More particularly, the invention relates to a method of prognosis of a patient afflicted with breast cancer, including determining the level of HER2/CB 2  heteromer expression in a biological sample obtained from the patient.

Claim (Index 1):
A method comprising:\n providing a test sample comprising a biological sample from a subject; contacting the test sample with a HER2/CB 2  heteromer binding composition to form a mixture; incubating the mixture for a time sufficient to permit binding; and determining from the mixture a level of HER2/CB 2  heteromer in the biological sample.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 95.0
- Lexical Diversity: 1.45455
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13705048', '12821664', '12854144', '13829234', '12074229']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5899165370333077
- 35 USC 102 Novelty (BERT): 0.4980754129500437
- Combined Prediction Score: 0.5807324246249814
- Mean Citation Score: 211.91263
- Max Citation Score: 232.68901
- Similarity Product: 151.13158422655286

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test